Creative Medical Technology Holdings, Inc. (CELZ) stock
CELZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.62−0.01 (-2.08%)
Close on Nov 12, 2026Market cap $4.06MP/E –Yield –
Creative Medical Technology enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Creative Medical Technology's enterprise value was -$4.60M on Nov 11, 2026, against $1.57M a year earlier. Over the last 5 years it ranged from -$4.60M to $236.49M, with a median of $1.63M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$4.60M | – |
| 2025 | Dec 31, 2025 | -$317.67K | – |
| 2024 | Dec 31, 2024 | -$3.19M | -267.3% |
| 2023 | Dec 29, 2023 | $1.91M | -94.8% |
| 2022 | Dec 30, 2022 | $36.68M | +16.1% |
| 2021 | Dec 31, 2021 | $31.59M | -100.0% |
| 2020 | Dec 31, 2020 | $66.13B | +1991.0% |
| 2019 | Dec 31, 2019 | $3.16B | -91.9% |
| 2018 | Dec 31, 2018 | $38.82B | +440.9% |
| 2017 | Dec 29, 2017 | $7.18B | -97.2% |
| 2016 | Dec 30, 2016 | $258.35B | +25832.2% |
| 2015 | Dec 31, 2015 | $996.25M | – |
See a number that looks wrong?